| Dr Shaun Peter Garff, DO | |
|
4560 Lake Ridge Parkway, Suite 300, Dallas, TX 75052-3460 | |
| (214) 278-5000 | |
| (214) 278-5001 |
| Full Name | Dr Shaun Peter Garff |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 10 Years |
| Location | 4560 Lake Ridge Parkway, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093135816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | Q5189 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Charlton Medical Center | Dallas, TX | Hospital |
| Methodist Mansfield Medical Center | Mansfield, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medhealth | 9931001567 | 306 |
| Physician Associates Of Southwest Dallas | 3274519293 | 30 |
News Archive
Niyati Parekh, an assistant professor at New York University's Steinhardt School of Culture, Education, and Human Development, has received a $720,000 Research Scholar Grant from the American Cancer Society to study the role of insulin in obesity-related cancers.
Beauty injectable fillers such as Restylane(R), Perlane(R) and Juvederm(R) are popular for their ability to restore years of lost facial volume in moments. But for the more sensitive aesthetic patient, the possibility of experiencing injection discomfort or bruising inhibits them from receiving the dramatic visual improvement that could be theirs.
Hospital readmissions, a $17 billion annual problem, are higher in rural, remote or smaller communities that sometimes have significantly less access to pharmacies, according to a study published today that was one of the first to examine this issue.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Oxaliplatin Injection (liquid) in the U.S. The U.S. Food and Drug Administration granted approval to market Oxaliplatin Injection in two dosage strengths to Fresenius Kabi Oncology Limited. APP Pharmaceuticals and Fresenius Kabi Oncology Limited are members of the Fresenius Kabi Group of companies. APP currently markets the lyophilized product, Oxaliplatin for Injection, 50 mg and 100 mg.
Researchers have found that a drug currently used to treat Type 2 diabetes could treat addiction to drugs such as cocaine.
› Verified 7 days ago
| Entity Name | Medhealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912957200 PECOS PAC ID: 9931001567 Enrollment ID: O20040123000832 |
News Archive
Niyati Parekh, an assistant professor at New York University's Steinhardt School of Culture, Education, and Human Development, has received a $720,000 Research Scholar Grant from the American Cancer Society to study the role of insulin in obesity-related cancers.
Beauty injectable fillers such as Restylane(R), Perlane(R) and Juvederm(R) are popular for their ability to restore years of lost facial volume in moments. But for the more sensitive aesthetic patient, the possibility of experiencing injection discomfort or bruising inhibits them from receiving the dramatic visual improvement that could be theirs.
Hospital readmissions, a $17 billion annual problem, are higher in rural, remote or smaller communities that sometimes have significantly less access to pharmacies, according to a study published today that was one of the first to examine this issue.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Oxaliplatin Injection (liquid) in the U.S. The U.S. Food and Drug Administration granted approval to market Oxaliplatin Injection in two dosage strengths to Fresenius Kabi Oncology Limited. APP Pharmaceuticals and Fresenius Kabi Oncology Limited are members of the Fresenius Kabi Group of companies. APP currently markets the lyophilized product, Oxaliplatin for Injection, 50 mg and 100 mg.
Researchers have found that a drug currently used to treat Type 2 diabetes could treat addiction to drugs such as cocaine.
› Verified 7 days ago
| Entity Name | Physician Associates Of Southwest Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801845425 PECOS PAC ID: 3274519293 Enrollment ID: O20040629000498 |
News Archive
Niyati Parekh, an assistant professor at New York University's Steinhardt School of Culture, Education, and Human Development, has received a $720,000 Research Scholar Grant from the American Cancer Society to study the role of insulin in obesity-related cancers.
Beauty injectable fillers such as Restylane(R), Perlane(R) and Juvederm(R) are popular for their ability to restore years of lost facial volume in moments. But for the more sensitive aesthetic patient, the possibility of experiencing injection discomfort or bruising inhibits them from receiving the dramatic visual improvement that could be theirs.
Hospital readmissions, a $17 billion annual problem, are higher in rural, remote or smaller communities that sometimes have significantly less access to pharmacies, according to a study published today that was one of the first to examine this issue.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Oxaliplatin Injection (liquid) in the U.S. The U.S. Food and Drug Administration granted approval to market Oxaliplatin Injection in two dosage strengths to Fresenius Kabi Oncology Limited. APP Pharmaceuticals and Fresenius Kabi Oncology Limited are members of the Fresenius Kabi Group of companies. APP currently markets the lyophilized product, Oxaliplatin for Injection, 50 mg and 100 mg.
Researchers have found that a drug currently used to treat Type 2 diabetes could treat addiction to drugs such as cocaine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shaun Peter Garff, DO 4560 Lake Ridge Parkway, Suite 300, Dallas, TX 75052-3460 Ph: (214) 278-5000 | Dr Shaun Peter Garff, DO 4560 Lake Ridge Parkway, Suite 300, Dallas, TX 75052-3460 Ph: (214) 278-5000 |
News Archive
Niyati Parekh, an assistant professor at New York University's Steinhardt School of Culture, Education, and Human Development, has received a $720,000 Research Scholar Grant from the American Cancer Society to study the role of insulin in obesity-related cancers.
Beauty injectable fillers such as Restylane(R), Perlane(R) and Juvederm(R) are popular for their ability to restore years of lost facial volume in moments. But for the more sensitive aesthetic patient, the possibility of experiencing injection discomfort or bruising inhibits them from receiving the dramatic visual improvement that could be theirs.
Hospital readmissions, a $17 billion annual problem, are higher in rural, remote or smaller communities that sometimes have significantly less access to pharmacies, according to a study published today that was one of the first to examine this issue.
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Oxaliplatin Injection (liquid) in the U.S. The U.S. Food and Drug Administration granted approval to market Oxaliplatin Injection in two dosage strengths to Fresenius Kabi Oncology Limited. APP Pharmaceuticals and Fresenius Kabi Oncology Limited are members of the Fresenius Kabi Group of companies. APP currently markets the lyophilized product, Oxaliplatin for Injection, 50 mg and 100 mg.
Researchers have found that a drug currently used to treat Type 2 diabetes could treat addiction to drugs such as cocaine.
› Verified 7 days ago
Dr. Juan F Quiroz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4811a Columbia Ave, Dallas, TX 75226 Phone: 214-823-5590 Fax: 214-823-6638 | |
Dr. Michelle Dobbs, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 6333 E Mockingbird Ln, Suite 126, Dallas, TX 75214 Phone: 214-826-6005 | |
Howard J Huntzinger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9250 Amberton Pkwy, Dallas, TX 75243 Phone: 682-236-3656 | |
Robert J Dimeff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8081 Walnut Hill Ln, Dallas, TX 75231 Phone: 214-750-1207 Fax: 214-739-5029 | |
Pardeep K Shori, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7012 La Vista Dr, Dallas, TX 75214 Phone: 817-564-5761 | |
Mary Elizabeth Wilcox Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 Fairmount St, Dallas, TX 75201 Phone: 214-742-9310 | |
Elizabeth Chapek, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 6760 Abrams Rd, Suite 203, Dallas, TX 75231 Phone: 214-341-8742 |